Angelman Syndrome impacts roughly 1 in 20,000 births. It is a neuro-genetic disorder that impacts patients’ movement, sleep, and cognitive function. There is no cure for Angelman Syndrome, and often patients live as long as anyone else, but with far more difficulty due to the seizures, intellectual disability, and speech impairment (among other symptoms) caused […]
Cognitive maps help us understand where we are, and remember how to navigate the world. For example, your brain (specifically, your hippocampus) has a map of your home – where tofind the kitchen, the bathroom, the bedroom, and so on. But it’s also important for your mental map to include the locations of things you […]
Researchers from the McKelvey School of Engineering and the Kepecs Lab have a new paper in Nature Neuroscience describing their development of a panoramically reconfigurable illuminative (PRIME) that offers a powerful platform for optical control of neural circuits across the brain.
A new paper in eLife from the Cavalli Lab reveals that inhibiting ETBR function enhances axon regeneration and rescues the age-dependent decrease in axonal regenerative capacity, providing a potential avenue for future therapies.
Lawrence Snyder, MD, PhD, is part of a new study in Nature Communications that demonstrates that artificial neurons can function as trans-functional devices (transneurons) that reconfigure their behavior to attain instantaneous computational needs, each capable of emulating several biological neurons.
Gaia Tavoni, PhD, and Kaining Zhang, PhD, have published a new paper that offers insights into the memory capacity of brain-inspired networks.
In a study published June 12 in The Journal of Neuroscience, WashU researchers show how they used optogenetics in the larval zebrafish to map the connectivity and activity of V2b neurons, a major inhibitory spinal population, to receive the results.
Tom Franken, MD, PhD, has recent papers published in iScience and Neuron that add new knowledge to how the brain processes complex visual input.
Thomas Papouin, PhD, assistant professor of neuroscience, is the senior author of a groundbreaking study published May 15 in Science.
In a study published April 11 in Science, Adam Kepecs, PhD, and other WashU Medicine researchers report they discovered a previously unrecognized pathway in the brain that senses inflammation and actively suppresses dopamine — a key driver of motivation — resulting in apathy and loss of drive.